Skip to content
RaiseKit
VCsFundsInvestmentsStart freePricing
RaiseKit

The most comprehensive database of web3 VCs. Built and maintained by AI agents.

Directory

  • VCs
  • Funds
  • Investments
  • Writing
  • Funding
  • Sectors
  • Geography

Resources

  • RSS Feed
  • Changelog
  • Search
  • Compare VCs
  • Reports
  • Activity
  • Deploying

Subscribe

Weekly digest of VC insights and funding rounds.

Subscribe to digest →

© 2026 RaiseKit. Data updated nightly by AI agents.

PrivacyTermsSupportDelete accountRSS
  1. Sectors
  2. /Healthcare IT

Healthcare IT

68 VCs and 10 funds investing in Healthcare IT

VCs investing in Healthcare IT

Mike Dowdle

Founding Partner

80%

Circadian Ventures

Check: Circadian Ventures does not publish a standard current check-size range on its official site.

Mike Dowdle invests or supports investments through Circadian Ventures's published strategy: Actively partner with exceptional technology entrepreneurs building enduring businesses across the United States.

SeedEarly Stage

Lister Delgado

Managing Partner

80%

IDEA Fund Partners

Check: IDEA Fund Partners does not publish a standard current check-size range on its official site.

Lister Delgado invests or supports investments through IDEA Fund Partners's published strategy: Back transformative early-stage technology founders, with a geographic emphasis on the Southeast and Mid-Atlantic and active help from investment and venture partners.

Pre-SeedSeedEarly Stage

John Cambier

Partner and Chief Financial Officer

80%

IDEA Fund Partners

Check: IDEA Fund Partners does not publish a standard current check-size range on its official site.

John Cambier is listed in a Partner and Chief Financial Officer capacity at IDEA Fund Partners. The firm does not publish a person-specific investment thesis for this role; the profile preserves that role distinction and uses the firm's mandate only as shared context.

Pre-SeedSeedEarly Stage

Juan Carlos Pacheco

Senior Associate

80%

IDEA Fund Partners

Check: IDEA Fund Partners does not publish a standard current check-size range on its official site.

Juan Carlos Pacheco invests or supports investments through IDEA Fund Partners's published strategy: Back transformative early-stage technology founders, with a geographic emphasis on the Southeast and Mid-Atlantic and active help from investment and venture partners.

Pre-SeedSeedEarly Stage

Dale Harber

Venture Partner

80%

IDEA Fund Partners

Check: IDEA Fund Partners does not publish a standard current check-size range on its official site.

Dale Harber invests or supports investments through IDEA Fund Partners's published strategy: Back transformative early-stage technology founders, with a geographic emphasis on the Southeast and Mid-Atlantic and active help from investment and venture partners.

Pre-SeedSeedEarly Stage

Kramer Reeves

Venture Partner

80%

IDEA Fund Partners

Check: IDEA Fund Partners does not publish a standard current check-size range on its official site.

Kramer Reeves invests or supports investments through IDEA Fund Partners's published strategy: Back transformative early-stage technology founders, with a geographic emphasis on the Southeast and Mid-Atlantic and active help from investment and venture partners.

Pre-SeedSeedEarly Stage

Wayne Hunter

Managing Partner

80%

Harbert Growth Partners

Check: Harbert Growth Partners does not publish a standard current check-size range on its official strategy page.

Wayne Hunter invests or supports investments through Harbert Growth Partners's published strategy: Invest in high-growth technology businesses with scalable platforms, recurring revenue, defensible positions and strong management across the Mid-Atlantic, Southeast, Southwest and Midwest.

Late Stage VentureGrowth Equity

Tom Roberts

General Partner

80%

Harbert Growth Partners

Check: Harbert Growth Partners does not publish a standard current check-size range on its official strategy page.

Tom Roberts invests or supports investments through Harbert Growth Partners's published strategy: Invest in high-growth technology businesses with scalable platforms, recurring revenue, defensible positions and strong management across the Mid-Atlantic, Southeast, Southwest and Midwest.

Late Stage VentureGrowth Equity

Brian Carney

General Partner

80%

Harbert Growth Partners

Check: Harbert Growth Partners does not publish a standard current check-size range on its official strategy page.

Brian Carney invests or supports investments through Harbert Growth Partners's published strategy: Invest in high-growth technology businesses with scalable platforms, recurring revenue, defensible positions and strong management across the Mid-Atlantic, Southeast, Southwest and Midwest.

Late Stage VentureGrowth Equity

Alison McKinney

Senior Associate

80%

Harbert Growth Partners

Check: Harbert Growth Partners does not publish a standard current check-size range on its official strategy page.

Alison McKinney invests or supports investments through Harbert Growth Partners's published strategy: Invest in high-growth technology businesses with scalable platforms, recurring revenue, defensible positions and strong management across the Mid-Atlantic, Southeast, Southwest and Midwest.

Late Stage VentureGrowth Equity

Alex Shandiz

General Partner

80%

Boomerang Ventures

Check: Boomerang Ventures does not publish a standard current check-size range on its official site.

Alex Shandiz invests or supports investments through Boomerang Ventures's published strategy: Build and invest in connected-health companies improving care quality, access, delivery, efficiency and patient experience, with particular attention to Midwest opportunities.

Pre-SeedSeedSeries A

Ariel MacTavish

Venture Partner

80%

Boomerang Ventures

Check: Boomerang Ventures does not publish a standard current check-size range on its official site.

Ariel MacTavish invests or supports investments through Boomerang Ventures's published strategy: Build and invest in connected-health companies improving care quality, access, delivery, efficiency and patient experience, with particular attention to Midwest opportunities.

Pre-SeedSeedSeries A

Audrey Beckman

Partner and Chief Innovation Officer

80%

Boomerang Ventures

Check: Boomerang Ventures does not publish a standard current check-size range on its official site.

Audrey Beckman invests or supports investments through Boomerang Ventures's published strategy: Build and invest in connected-health companies improving care quality, access, delivery, efficiency and patient experience, with particular attention to Midwest opportunities.

Pre-SeedSeedSeries A

Dick Aderman

Studio Director

80%

Boomerang Ventures

Check: Boomerang Ventures does not publish a standard current check-size range on its official site.

Dick Aderman is listed in a Studio Director capacity at Boomerang Ventures. The firm does not publish a person-specific investment thesis for this role; the profile preserves that role distinction and uses the firm's mandate only as shared context.

Pre-SeedSeedSeries A

Oscar Moralez

Founder and Managing Partner

80%

Boomerang Ventures

Check: Boomerang Ventures does not publish a standard current check-size range on its official site.

Oscar Moralez invests or supports investments through Boomerang Ventures's published strategy: Build and invest in connected-health companies improving care quality, access, delivery, efficiency and patient experience, with particular attention to Midwest opportunities.

Pre-SeedSeedSeries A

Todd R. Lugar

Controller and HR Lead

80%

Boomerang Ventures

Check: Boomerang Ventures does not publish a standard current check-size range on its official site.

Todd R. Lugar is listed in a Controller and HR Lead capacity at Boomerang Ventures. The firm does not publish a person-specific investment thesis for this role; the profile preserves that role distinction and uses the firm's mandate only as shared context.

Pre-SeedSeedSeries A

Tony Petrucciani

Partner and Chief Financial Officer

80%

Boomerang Ventures

Check: Boomerang Ventures does not publish a standard current check-size range on its official site.

Tony Petrucciani is listed in a Partner and Chief Financial Officer capacity at Boomerang Ventures. The firm does not publish a person-specific investment thesis for this role; the profile preserves that role distinction and uses the firm's mandate only as shared context.

Pre-SeedSeedSeries A

Ben Trumbull

Managing Partner

80%

Tamarind Hill

Check: $2M-$7M seed rounds, as published by Tamarind Hill.

Ben Trumbull invests or supports investments through Tamarind Hill's published strategy: Lead seed rounds for B2B healthcare companies with early product-market fit across decentralized care, care economics and healthcare supply-chain innovation.

SeedEarly Stage

Josh Buehler

Operating Partner

80%

Tamarind Hill

Check: $2M-$7M seed rounds, as published by Tamarind Hill.

Josh Buehler invests or supports investments through Tamarind Hill's published strategy: Lead seed rounds for B2B healthcare companies with early product-market fit across decentralized care, care economics and healthcare supply-chain innovation.

SeedEarly Stage

Christie Currie

Senior Associate

80%

Tamarind Hill

Check: $2M-$7M seed rounds, as published by Tamarind Hill.

Christie Currie invests or supports investments through Tamarind Hill's published strategy: Lead seed rounds for B2B healthcare companies with early product-market fit across decentralized care, care economics and healthcare supply-chain innovation.

SeedEarly Stage

Allison Weiland

Finance and Operations Manager

80%

Tamarind Hill

Check: $2M-$7M seed rounds, as published by Tamarind Hill.

Allison Weiland is listed in a Finance and Operations Manager capacity at Tamarind Hill. The firm does not publish a person-specific investment thesis for this role; the profile preserves that role distinction and uses the firm's mandate only as shared context.

SeedEarly Stage

Steve Hasty

Principal

80%

Circadian Ventures

Check: Circadian Ventures does not publish a standard current check-size range on its official site.

Steve Hasty invests or supports investments through Circadian Ventures's published strategy: Actively partner with exceptional technology entrepreneurs building enduring businesses across the United States.

SeedEarly Stage

Bill Trainor

Co-Founder and Partner

80%

Mutual Capital Partners

Check: Mutual Capital Partners does not publish a standard current check-size range on its official site.

Bill Trainor invests or supports investments through Mutual Capital Partners's published strategy: Partner with healthcare IT and medical-device companies outside major technology centers that have strong teams, reference customers, meaningful revenue and attractive margins.

Early StageGrowth

Wayne Wallace

Co-Founder and Partner

80%

Mutual Capital Partners

Check: Mutual Capital Partners does not publish a standard current check-size range on its official site.

Wayne Wallace invests or supports investments through Mutual Capital Partners's published strategy: Partner with healthcare IT and medical-device companies outside major technology centers that have strong teams, reference customers, meaningful revenue and attractive margins.

Early StageGrowth

Zakiya Alta Lee-Hill

Principal

80%

IDEA Fund Partners

Check: IDEA Fund Partners does not publish a standard current check-size range on its official site.

Zakiya Alta Lee-Hill invests or supports investments through IDEA Fund Partners's published strategy: Back transformative early-stage technology founders, with a geographic emphasis on the Southeast and Mid-Atlantic and active help from investment and venture partners.

Pre-SeedSeedEarly Stage

Greg Lissy

Venture Partner

80%

IDEA Fund Partners

Check: IDEA Fund Partners does not publish a standard current check-size range on its official site.

Greg Lissy invests or supports investments through IDEA Fund Partners's published strategy: Back transformative early-stage technology founders, with a geographic emphasis on the Southeast and Mid-Atlantic and active help from investment and venture partners.

Pre-SeedSeedEarly Stage

Windy Kohl

Venture Partner

80%

IDEA Fund Partners

Check: IDEA Fund Partners does not publish a standard current check-size range on its official site.

Windy Kohl invests or supports investments through IDEA Fund Partners's published strategy: Back transformative early-stage technology founders, with a geographic emphasis on the Southeast and Mid-Atlantic and active help from investment and venture partners.

Pre-SeedSeedEarly Stage

Ally Thill

Project Leader

80%

Boomerang Ventures

Check: Boomerang Ventures does not publish a standard current check-size range on its official site.

Ally Thill is listed in a Project Leader capacity at Boomerang Ventures. The firm does not publish a person-specific investment thesis for this role; the profile preserves that role distinction and uses the firm's mandate only as shared context.

Pre-SeedSeedSeries A

Dan Clark

Venture Partner

80%

Boomerang Ventures

Check: Boomerang Ventures does not publish a standard current check-size range on its official site.

Dan Clark invests or supports investments through Boomerang Ventures's published strategy: Build and invest in connected-health companies improving care quality, access, delivery, efficiency and patient experience, with particular attention to Midwest opportunities.

Pre-SeedSeedSeries A

David Helmer

Partner

80%

Boomerang Ventures

Check: Boomerang Ventures does not publish a standard current check-size range on its official site.

David Helmer invests or supports investments through Boomerang Ventures's published strategy: Build and invest in connected-health companies improving care quality, access, delivery, efficiency and patient experience, with particular attention to Midwest opportunities.

Pre-SeedSeedSeries A

Eric Beier

Partner and Chief Medical Officer

80%

Boomerang Ventures

Check: Boomerang Ventures does not publish a standard current check-size range on its official site.

Eric Beier invests or supports investments through Boomerang Ventures's published strategy: Build and invest in connected-health companies improving care quality, access, delivery, efficiency and patient experience, with particular attention to Midwest opportunities.

Pre-SeedSeedSeries A

Tejas Vijh

Associate

80%

Boomerang Ventures

Check: Boomerang Ventures does not publish a standard current check-size range on its official site.

Tejas Vijh invests or supports investments through Boomerang Ventures's published strategy: Build and invest in connected-health companies improving care quality, access, delivery, efficiency and patient experience, with particular attention to Midwest opportunities.

Pre-SeedSeedSeries A

Mark Shary

Managing Partner

80%

Tamarind Hill

Check: $2M-$7M seed rounds, as published by Tamarind Hill.

Mark Shary invests or supports investments through Tamarind Hill's published strategy: Lead seed rounds for B2B healthcare companies with early product-market fit across decentralized care, care economics and healthcare supply-chain innovation.

SeedEarly Stage

Liz Todia Zambory

Principal

80%

Mutual Capital Partners

Check: Mutual Capital Partners does not publish a standard current check-size range on its official site.

Liz Todia Zambory invests or supports investments through Mutual Capital Partners's published strategy: Partner with healthcare IT and medical-device companies outside major technology centers that have strong teams, reference customers, meaningful revenue and attractive margins.

Early StageGrowth

Will Brune

Senior Associate

80%

Mutual Capital Partners

Check: Mutual Capital Partners does not publish a standard current check-size range on its official site.

Will Brune invests or supports investments through Mutual Capital Partners's published strategy: Partner with healthcare IT and medical-device companies outside major technology centers that have strong teams, reference customers, meaningful revenue and attractive margins.

Early StageGrowth

Daniel Fleming

Managing Partner

80%

RC Capital

Check: RC Capital does not publish a standard check-size range on its current official website.

Daniel Fleming contributes to RC Capital's published strategy: Build high-potential healthcare companies that improve care delivery, patient experience and outcomes across devices, services and healthcare IT.

Growth StageLower Middle Market

J. Carter McNabb

Managing Partner

80%

RC Capital

Check: RC Capital does not publish a standard check-size range on its current official website.

J. Carter McNabb contributes to RC Capital's published strategy: Build high-potential healthcare companies that improve care delivery, patient experience and outcomes across devices, services and healthcare IT.

Growth StageLower Middle Market

Robert Heimann

Managing Partner

80%

RC Capital

Check: RC Capital does not publish a standard check-size range on its current official website.

Robert Heimann contributes to RC Capital's published strategy: Build high-potential healthcare companies that improve care delivery, patient experience and outcomes across devices, services and healthcare IT.

Growth StageLower Middle Market

Rurik “Rik” Vandevenne

Managing Partner

80%

RC Capital

Check: RC Capital does not publish a standard check-size range on its current official website.

Rurik “Rik” Vandevenne contributes to RC Capital's published strategy: Build high-potential healthcare companies that improve care delivery, patient experience and outcomes across devices, services and healthcare IT.

Growth StageLower Middle Market

Patrick Dunnigan

Partner

80%

RC Capital

Check: RC Capital does not publish a standard check-size range on its current official website.

Patrick Dunnigan contributes to RC Capital's published strategy: Build high-potential healthcare companies that improve care delivery, patient experience and outcomes across devices, services and healthcare IT.

Growth StageLower Middle Market

Adrienne Vannarsdall

CFO

80%

RC Capital

Check: RC Capital does not publish a standard check-size range on its current official website.

Adrienne Vannarsdall contributes to RC Capital's published strategy: Build high-potential healthcare companies that improve care delivery, patient experience and outcomes across devices, services and healthcare IT.

Growth StageLower Middle Market

Parag Rathi

Principal

80%

RC Capital

Check: RC Capital does not publish a standard check-size range on its current official website.

Parag Rathi contributes to RC Capital's published strategy: Build high-potential healthcare companies that improve care delivery, patient experience and outcomes across devices, services and healthcare IT.

Growth StageLower Middle Market

Vitaly Goldfeder

Principal

80%

RC Capital

Check: RC Capital does not publish a standard check-size range on its current official website.

Vitaly Goldfeder contributes to RC Capital's published strategy: Build high-potential healthcare companies that improve care delivery, patient experience and outcomes across devices, services and healthcare IT.

Growth StageLower Middle Market

Britney Hamberg

Principal, Investor Relations & Operations

80%

RC Capital

Check: RC Capital does not publish a standard check-size range on its current official website.

Britney Hamberg contributes to RC Capital's published strategy: Build high-potential healthcare companies that improve care delivery, patient experience and outcomes across devices, services and healthcare IT.

Growth StageLower Middle Market

Dana Tanenbaum

Controller

80%

RC Capital

Check: RC Capital does not publish a standard check-size range on its current official website.

Dana Tanenbaum contributes to RC Capital's published strategy: Build high-potential healthcare companies that improve care delivery, patient experience and outcomes across devices, services and healthcare IT.

Growth StageLower Middle Market

Paul Axelrod

Vice President

80%

RC Capital

Check: RC Capital does not publish a standard check-size range on its current official website.

Paul Axelrod contributes to RC Capital's published strategy: Build high-potential healthcare companies that improve care delivery, patient experience and outcomes across devices, services and healthcare IT.

Growth StageLower Middle Market

Scott Steever

Vice President

80%

RC Capital

Check: RC Capital does not publish a standard check-size range on its current official website.

Scott Steever contributes to RC Capital's published strategy: Build high-potential healthcare companies that improve care delivery, patient experience and outcomes across devices, services and healthcare IT.

Growth StageLower Middle Market

Ryan Moeller

Vice President

80%

RC Capital

Check: RC Capital does not publish a standard check-size range on its current official website.

Ryan Moeller contributes to RC Capital's published strategy: Build high-potential healthcare companies that improve care delivery, patient experience and outcomes across devices, services and healthcare IT.

Growth StageLower Middle Market

Marcus Fields

Senior Associate

80%

RC Capital

Check: RC Capital does not publish a standard check-size range on its current official website.

Marcus Fields contributes to RC Capital's published strategy: Build high-potential healthcare companies that improve care delivery, patient experience and outcomes across devices, services and healthcare IT.

Growth StageLower Middle Market

Saloni Rai

Analyst, Investor Relations

80%

RC Capital

Check: RC Capital does not publish a standard check-size range on its current official website.

Saloni Rai contributes to RC Capital's published strategy: Build high-potential healthcare companies that improve care delivery, patient experience and outcomes across devices, services and healthcare IT.

Growth StageLower Middle Market

Kushal Modi

Analyst, Investments

80%

RC Capital

Check: RC Capital does not publish a standard check-size range on its current official website.

Kushal Modi contributes to RC Capital's published strategy: Build high-potential healthcare companies that improve care delivery, patient experience and outcomes across devices, services and healthcare IT.

Growth StageLower Middle Market

Britney Byrd

Analyst, Finance

80%

RC Capital

Check: RC Capital does not publish a standard check-size range on its current official website.

Britney Byrd contributes to RC Capital's published strategy: Build high-potential healthcare companies that improve care delivery, patient experience and outcomes across devices, services and healthcare IT.

Growth StageLower Middle Market

Kaity Lynch

Manager of Administration

80%

RC Capital

Check: RC Capital does not publish a standard check-size range on its current official website.

Kaity Lynch contributes to RC Capital's published strategy: Build high-potential healthcare companies that improve care delivery, patient experience and outcomes across devices, services and healthcare IT.

Growth StageLower Middle Market

Mark Bakken

Managing Partner

80%

HealthX Ventures

Check: HealthX Ventures does not publish a standard check-size range on its current official website.

Mark Bakken contributes to HealthX Ventures's published strategy: Lead seed equity rounds in scalable digital-health companies and actively help with healthcare customers, teams, operations and syndicates.

Pre-RevenueSeedEarly Stage

Samantha McGrandy

Chief Financial Officer

80%

HealthX Ventures

Check: HealthX Ventures does not publish a standard check-size range on its current official website.

Samantha McGrandy contributes to HealthX Ventures's published strategy: Lead seed equity rounds in scalable digital-health companies and actively help with healthcare customers, teams, operations and syndicates.

Pre-RevenueSeedEarly Stage

Darcey Nett

Partner

80%

HealthX Ventures

Check: HealthX Ventures does not publish a standard check-size range on its current official website.

Darcey Nett contributes to HealthX Ventures's published strategy: Lead seed equity rounds in scalable digital-health companies and actively help with healthcare customers, teams, operations and syndicates.

Pre-RevenueSeedEarly Stage

Brian Lindstrom

Partner

80%

HealthX Ventures

Check: HealthX Ventures does not publish a standard check-size range on its current official website.

Brian Lindstrom contributes to HealthX Ventures's published strategy: Lead seed equity rounds in scalable digital-health companies and actively help with healthcare customers, teams, operations and syndicates.

Pre-RevenueSeedEarly Stage

Laura Hilty

Principal

80%

HealthX Ventures

Check: HealthX Ventures does not publish a standard check-size range on its current official website.

Laura Hilty contributes to HealthX Ventures's published strategy: Lead seed equity rounds in scalable digital-health companies and actively help with healthcare customers, teams, operations and syndicates.

Pre-RevenueSeedEarly Stage

Shannon Flaherty

VP, Operations & Compliance

80%

HealthX Ventures

Check: HealthX Ventures does not publish a standard check-size range on its current official website.

Shannon Flaherty contributes to HealthX Ventures's published strategy: Lead seed equity rounds in scalable digital-health companies and actively help with healthcare customers, teams, operations and syndicates.

Pre-RevenueSeedEarly Stage

Alexis Johnson

Chief of Staff

80%

HealthX Ventures

Check: HealthX Ventures does not publish a standard check-size range on its current official website.

Alexis Johnson contributes to HealthX Ventures's published strategy: Lead seed equity rounds in scalable digital-health companies and actively help with healthcare customers, teams, operations and syndicates.

Pre-RevenueSeedEarly Stage

Kayla Liederbach

Fractional Head of Marketing

80%

HealthX Ventures

Check: HealthX Ventures does not publish a standard check-size range on its current official website.

Kayla Liederbach contributes to HealthX Ventures's published strategy: Lead seed equity rounds in scalable digital-health companies and actively help with healthcare customers, teams, operations and syndicates.

Pre-RevenueSeedEarly Stage

Emma Merrick

Associate

80%

HealthX Ventures

Check: HealthX Ventures does not publish a standard check-size range on its current official website.

Emma Merrick contributes to HealthX Ventures's published strategy: Lead seed equity rounds in scalable digital-health companies and actively help with healthcare customers, teams, operations and syndicates.

Pre-RevenueSeedEarly Stage

Dan Neill

Venture Consultant

80%

HealthX Ventures

Check: HealthX Ventures does not publish a standard check-size range on its current official website.

Dan Neill contributes to HealthX Ventures's published strategy: Lead seed equity rounds in scalable digital-health companies and actively help with healthcare customers, teams, operations and syndicates.

Pre-RevenueSeedEarly Stage

Hardik Desai

Managing Partner and NEXT Fund Manager

80%

JumpStart Ventures

Check: JumpStart Ventures does not publish one standard check-size range across its multiple funds.

Hardik Desai invests or supports investments through JumpStart Ventures's published strategy: Invest through multiple funds in high-potential Ohio and Midwest technology startups from pre-seed through Series A and beyond.

Pre-SeedSeedSeries A

Karim Botros

Board Member and Chair, Investment Committee

80%

JumpStart Ventures

Check: JumpStart Ventures does not publish one standard check-size range across its multiple funds.

Karim Botros invests or supports investments through JumpStart Ventures's published strategy: Invest through multiple funds in high-potential Ohio and Midwest technology startups from pre-seed through Series A and beyond.

Pre-SeedSeedSeries A

Joshua Borstein, Ph.D.

Investment Principal

80%

JumpStart Ventures

Check: JumpStart Ventures does not publish one standard check-size range across its multiple funds.

Joshua Borstein, Ph.D. invests or supports investments through JumpStart Ventures's published strategy: Invest through multiple funds in high-potential Ohio and Midwest technology startups from pre-seed through Series A and beyond.

Pre-SeedSeedSeries A

Will Stabler

Fund Operations Manager

80%

JumpStart Ventures

Check: JumpStart Ventures does not publish one standard check-size range across its multiple funds.

Will Stabler is listed in a Fund Operations Manager capacity at JumpStart Ventures. No person-specific investment thesis is published for this role; the firm's mandate is included only as shared context.

Pre-SeedSeedSeries A

Bethany George

Fund Manager, Evergreen and Focus Funds

80%

JumpStart Ventures

Check: JumpStart Ventures does not publish one standard check-size range across its multiple funds.

Bethany George invests or supports investments through JumpStart Ventures's published strategy: Invest through multiple funds in high-potential Ohio and Midwest technology startups from pre-seed through Series A and beyond.

Pre-SeedSeedSeries A

Funds focused on Healthcare IT

RC Capital

Cincinnati, Ohio / Raleigh, North Carolina

18 people0 investments

Boomerang Ventures

Indianapolis, Indiana

12 people0 investments

HealthX Ventures

Madison, Wisconsin

10 people0 investments

IDEA Fund Partners

Chapel Hill, North Carolina

8 people0 investments

JumpStart Ventures

Cleveland, Ohio

AUM: $140M+ under management

5 people0 investments

Harbert Growth Partners

Richmond, Virginia

4 people0 investments

Mutual Capital Partners

Westlake, Ohio

4 people0 investments

Tamarind Hill

Dublin, Ohio

5 people0 investments

Circadian Ventures

Atlanta, Georgia

2 people0 investments

M25

Chicago, IL, USA

0 people0 investments